HemaSphere

ISSNs: 2572-9241

Additional searchable ISSN (electronic): 2572-9241

John Wiley and Sons Inc.

Scopus rating (2023): CiteScore 6.1 SJR 1.191 SNIP 1.119

Indexed in DOAJ

Journal

Titles	HemaSphere HemaSphere
ISSNs	2572-9241
Additional searchable ISSN (electronic)	2572-9241
Publisher	John Wiley and Sons Inc.
ZDB-ID	2922183-3

Keywords

ASJC Scopus subject areas

Hematology

Library keywords

610 Medicine and health

Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemia

Larue, M., Labopin, M., Schroeder, T., Huang, X.-J., Blau, I. W., Schetelig, J. & Ganser, A. & 11 others, Hamladji, R.-M., Bethge, W., Kröger, N., Socié, G., Salmenniemi, U., Sengeloev, H., Dholaria, B., Savani, B. N., Nagler, A., Ciceri, F. & Mohty, M., Oct 2024, In: HemaSphere. 8, 10, p. e70026 e70026.

Research output: Contribution to journal › Research article › Contributed › peer-review

Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS

Mazzeo, P., Ganster, C., Wiedenhöft, J., Shirneshan, K., Rittscher, K., Brzuszkiewicz, E. B. & Steinemann, D. & 11 others, Schieck, M., Müller-Thomas, C., Treiber, H., Braulke, F., Germing, U., Sockel, K., Balaian, E., Schanz, J., Platzbecker, U., Götze, K. S. & Haase, D., Sept 2024, In: HemaSphere. 8, 9, p. e70014 e70014.

Research output: Contribution to journal › Research article › Contributed › peer-review

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium

i4MDS consortium, Winter, S., Sockel, K. & Oelschlaegel, U., 15 May 2024, In: HemaSphere. 8, 5, p. 1-16 16 p., e64.

Research output: Contribution to journal › Research article › Contributed › peer-review

Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?

Schwind, S., Bischof, L., Bill, M., Grimm, J., Ussmann, J., Backhaus, D. & Brauer, D. & 8 others, Thanh, T. P., Merz, M., Franke, G.-N., Metzeler, K. H., Vucinic, V., Herling, M., Platzbecker, U. & Jentzsch, M., Mar 2024, In: HemaSphere. 8, 3, e55.

Research output: Contribution to journal › Letter › Contributed › peer-review

Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade

Schewe, D. M., Vogiatzi, F., Münnich, I. A., Zeller, T., Windisch, R., Wichmann, C. & Müller, K. & 9 others, Bhat, H., Felix, E., Mougiakakos, D., Bruns, H., Lenk, L., Valerius, T., Humpe, A., Peipp, M. & Kellner, C., 22 Feb 2024, In: HemaSphere. 8, 2, e48.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (8)

Research Portal of the TU Dresden

HemaSphere

Keywords

ASJC Scopus subject areas

Library keywords

Related content

Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemia

Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium

Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?

Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade